Trial Profile
Japanese phase II study of Avastin plus paclitaxel and cisplatin in patients with advanced or recurrent cervical cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Apr 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cervical cancer
- Focus Adverse reactions
- 23 May 2016 According to Chugai media release, on September 14, 2015, Avastin was granted orphan drug desination advanced or recurrent cervical cancer.
- 18 Sep 2015 New trial record